Therapeutic activity of lipoxin A4 in TiO2-induced arthritis in mice: NF-κB and Nrf2 in synovial fluid leukocytes and neuronal TRPV1 mechanisms

BackgroundLipoxin A4 (LXA4) has anti-inflammatory and pro-resolutive roles in inflammation. We evaluated the effects and mechanisms of action of LXA4 in titanium dioxide (TiO2) arthritis, a model of prosthesis-induced joint inflammation and pain.MethodsMice were stimulated with TiO2 (3mg) in the kne...

Full description

Bibliographic Details
Main Authors: Telma Saraiva-Santos, Tiago H. Zaninelli, Marília F. Manchope, Ketlem C. Andrade, Camila R. Ferraz, Mariana M. Bertozzi, Nayara A. Artero, Anelise Franciosi, Stephanie Badaro-Garcia, Larissa Staurengo-Ferrari, Sergio M. Borghi, Graziela S. Ceravolo, Avacir Casanova Andrello, Janaína Menezes Zanoveli, Michael S. Rogers, Rubia Casagrande, Felipe A. Pinho-Ribeiro, Waldiceu A. Verri
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.949407/full
_version_ 1827926193265967104
author Telma Saraiva-Santos
Telma Saraiva-Santos
Tiago H. Zaninelli
Tiago H. Zaninelli
Tiago H. Zaninelli
Marília F. Manchope
Ketlem C. Andrade
Camila R. Ferraz
Mariana M. Bertozzi
Nayara A. Artero
Anelise Franciosi
Stephanie Badaro-Garcia
Larissa Staurengo-Ferrari
Sergio M. Borghi
Sergio M. Borghi
Graziela S. Ceravolo
Avacir Casanova Andrello
Janaína Menezes Zanoveli
Michael S. Rogers
Rubia Casagrande
Felipe A. Pinho-Ribeiro
Waldiceu A. Verri
author_facet Telma Saraiva-Santos
Telma Saraiva-Santos
Tiago H. Zaninelli
Tiago H. Zaninelli
Tiago H. Zaninelli
Marília F. Manchope
Ketlem C. Andrade
Camila R. Ferraz
Mariana M. Bertozzi
Nayara A. Artero
Anelise Franciosi
Stephanie Badaro-Garcia
Larissa Staurengo-Ferrari
Sergio M. Borghi
Sergio M. Borghi
Graziela S. Ceravolo
Avacir Casanova Andrello
Janaína Menezes Zanoveli
Michael S. Rogers
Rubia Casagrande
Felipe A. Pinho-Ribeiro
Waldiceu A. Verri
author_sort Telma Saraiva-Santos
collection DOAJ
description BackgroundLipoxin A4 (LXA4) has anti-inflammatory and pro-resolutive roles in inflammation. We evaluated the effects and mechanisms of action of LXA4 in titanium dioxide (TiO2) arthritis, a model of prosthesis-induced joint inflammation and pain.MethodsMice were stimulated with TiO2 (3mg) in the knee joint followed by LXA4 (0.1, 1, or 10ng/animal) or vehicle (ethanol 3.2% in saline) administration. Pain-like behavior, inflammation, and dosages were performed to assess the effects of LXA4in vivo.ResultsLXA4 reduced mechanical and thermal hyperalgesia, histopathological damage, edema, and recruitment of leukocytes without liver, kidney, or stomach toxicity. LXA4 reduced leukocyte migration and modulated cytokine production. These effects were explained by reduced nuclear factor kappa B (NFκB) activation in recruited macrophages. LXA4 improved antioxidant parameters [reduced glutathione (GSH) and 2,2-azino-bis 3-ethylbenzothiazoline-6-sulfonate (ABTS) levels, nuclear factor erythroid 2-related factor 2 (Nrf2) mRNA and Nrf2 protein expression], reducing reactive oxygen species (ROS) fluorescent detection induced by TiO2 in synovial fluid leukocytes. We observed an increase of lipoxin receptor (ALX/FPR2) in transient receptor potential cation channel subfamily V member 1 (TRPV1)+ DRG nociceptive neurons upon TiO2 inflammation. LXA4 reduced TiO2‐induced TRPV1 mRNA expression and protein detection, as well TRPV1 co-staining with p-NFκB, indicating reduction of neuronal activation. LXA4 down-modulated neuronal activation and response to capsaicin (a TRPV1 agonist) and AITC [a transient receptor potential ankyrin 1 (TRPA1) agonist] of DRG neurons.ConclusionLXA4 might target recruited leukocytes and primary afferent nociceptive neurons to exert analgesic and anti-inflammatory activities in a model resembling what is observed in patients with prosthesis inflammation.
first_indexed 2024-03-13T05:35:51Z
format Article
id doaj.art-bcd1d34c704c4929903bb0223edab626
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-13T05:35:51Z
publishDate 2023-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-bcd1d34c704c4929903bb0223edab6262023-06-14T08:26:13ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-06-011410.3389/fimmu.2023.949407949407Therapeutic activity of lipoxin A4 in TiO2-induced arthritis in mice: NF-κB and Nrf2 in synovial fluid leukocytes and neuronal TRPV1 mechanismsTelma Saraiva-Santos0Telma Saraiva-Santos1Tiago H. Zaninelli2Tiago H. Zaninelli3Tiago H. Zaninelli4Marília F. Manchope5Ketlem C. Andrade6Camila R. Ferraz7Mariana M. Bertozzi8Nayara A. Artero9Anelise Franciosi10Stephanie Badaro-Garcia11Larissa Staurengo-Ferrari12Sergio M. Borghi13Sergio M. Borghi14Graziela S. Ceravolo15Avacir Casanova Andrello16Janaína Menezes Zanoveli17Michael S. Rogers18Rubia Casagrande19Felipe A. Pinho-Ribeiro20Waldiceu A. Verri21Laboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina, Paraná, BrazilDivision of Dermatology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United StatesLaboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina, Paraná, BrazilDivision of Dermatology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United StatesVascular Biology Program, Department of Surgery, Boston Children's Hospital-Harvard Medical School, Boston, MA, United StatesLaboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina, Paraná, BrazilLaboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina, Paraná, BrazilLaboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina, Paraná, BrazilLaboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina, Paraná, BrazilLaboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina, Paraná, BrazilLaboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina, Paraná, BrazilLaboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina, Paraná, BrazilLaboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina, Paraná, BrazilLaboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina, Paraná, BrazilCenter for Research in Health Sciences, University of Northern Paraná, Londrina, Paraná, BrazilDepartment of Physiological Sciences, Center for Biological Sciences, Londrina State University, Londrina, Paraná, BrazilDepartment of Physics, Londrina State University, Londrina, Paraná, BrazilDepartment of Pharmacology, Biological Sciences Sector, Federal University of Parana, Curitiba, Parana, BrazilVascular Biology Program, Department of Surgery, Boston Children's Hospital-Harvard Medical School, Boston, MA, United StatesDepartment of Pharmaceutical Sciences, Centre of Health Sciences, Londrina State University, Londrina, Paraná, BrazilDivision of Dermatology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United StatesLaboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina, Paraná, BrazilBackgroundLipoxin A4 (LXA4) has anti-inflammatory and pro-resolutive roles in inflammation. We evaluated the effects and mechanisms of action of LXA4 in titanium dioxide (TiO2) arthritis, a model of prosthesis-induced joint inflammation and pain.MethodsMice were stimulated with TiO2 (3mg) in the knee joint followed by LXA4 (0.1, 1, or 10ng/animal) or vehicle (ethanol 3.2% in saline) administration. Pain-like behavior, inflammation, and dosages were performed to assess the effects of LXA4in vivo.ResultsLXA4 reduced mechanical and thermal hyperalgesia, histopathological damage, edema, and recruitment of leukocytes without liver, kidney, or stomach toxicity. LXA4 reduced leukocyte migration and modulated cytokine production. These effects were explained by reduced nuclear factor kappa B (NFκB) activation in recruited macrophages. LXA4 improved antioxidant parameters [reduced glutathione (GSH) and 2,2-azino-bis 3-ethylbenzothiazoline-6-sulfonate (ABTS) levels, nuclear factor erythroid 2-related factor 2 (Nrf2) mRNA and Nrf2 protein expression], reducing reactive oxygen species (ROS) fluorescent detection induced by TiO2 in synovial fluid leukocytes. We observed an increase of lipoxin receptor (ALX/FPR2) in transient receptor potential cation channel subfamily V member 1 (TRPV1)+ DRG nociceptive neurons upon TiO2 inflammation. LXA4 reduced TiO2‐induced TRPV1 mRNA expression and protein detection, as well TRPV1 co-staining with p-NFκB, indicating reduction of neuronal activation. LXA4 down-modulated neuronal activation and response to capsaicin (a TRPV1 agonist) and AITC [a transient receptor potential ankyrin 1 (TRPA1) agonist] of DRG neurons.ConclusionLXA4 might target recruited leukocytes and primary afferent nociceptive neurons to exert analgesic and anti-inflammatory activities in a model resembling what is observed in patients with prosthesis inflammation.https://www.frontiersin.org/articles/10.3389/fimmu.2023.949407/fulllipoxin A4TiO2ALX/FPR2inflammationTRPV1ROS
spellingShingle Telma Saraiva-Santos
Telma Saraiva-Santos
Tiago H. Zaninelli
Tiago H. Zaninelli
Tiago H. Zaninelli
Marília F. Manchope
Ketlem C. Andrade
Camila R. Ferraz
Mariana M. Bertozzi
Nayara A. Artero
Anelise Franciosi
Stephanie Badaro-Garcia
Larissa Staurengo-Ferrari
Sergio M. Borghi
Sergio M. Borghi
Graziela S. Ceravolo
Avacir Casanova Andrello
Janaína Menezes Zanoveli
Michael S. Rogers
Rubia Casagrande
Felipe A. Pinho-Ribeiro
Waldiceu A. Verri
Therapeutic activity of lipoxin A4 in TiO2-induced arthritis in mice: NF-κB and Nrf2 in synovial fluid leukocytes and neuronal TRPV1 mechanisms
Frontiers in Immunology
lipoxin A4
TiO2
ALX/FPR2
inflammation
TRPV1
ROS
title Therapeutic activity of lipoxin A4 in TiO2-induced arthritis in mice: NF-κB and Nrf2 in synovial fluid leukocytes and neuronal TRPV1 mechanisms
title_full Therapeutic activity of lipoxin A4 in TiO2-induced arthritis in mice: NF-κB and Nrf2 in synovial fluid leukocytes and neuronal TRPV1 mechanisms
title_fullStr Therapeutic activity of lipoxin A4 in TiO2-induced arthritis in mice: NF-κB and Nrf2 in synovial fluid leukocytes and neuronal TRPV1 mechanisms
title_full_unstemmed Therapeutic activity of lipoxin A4 in TiO2-induced arthritis in mice: NF-κB and Nrf2 in synovial fluid leukocytes and neuronal TRPV1 mechanisms
title_short Therapeutic activity of lipoxin A4 in TiO2-induced arthritis in mice: NF-κB and Nrf2 in synovial fluid leukocytes and neuronal TRPV1 mechanisms
title_sort therapeutic activity of lipoxin a4 in tio2 induced arthritis in mice nf κb and nrf2 in synovial fluid leukocytes and neuronal trpv1 mechanisms
topic lipoxin A4
TiO2
ALX/FPR2
inflammation
TRPV1
ROS
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.949407/full
work_keys_str_mv AT telmasaraivasantos therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT telmasaraivasantos therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT tiagohzaninelli therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT tiagohzaninelli therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT tiagohzaninelli therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT mariliafmanchope therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT ketlemcandrade therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT camilarferraz therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT marianambertozzi therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT nayaraaartero therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT anelisefranciosi therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT stephaniebadarogarcia therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT larissastaurengoferrari therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT sergiomborghi therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT sergiomborghi therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT grazielasceravolo therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT avacircasanovaandrello therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT janainamenezeszanoveli therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT michaelsrogers therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT rubiacasagrande therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT felipeapinhoribeiro therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms
AT waldiceuaverri therapeuticactivityoflipoxina4intio2inducedarthritisinmicenfkbandnrf2insynovialfluidleukocytesandneuronaltrpv1mechanisms